David Shaw’s Agios Pharmaceuticals AGIO Stock Holding History

David Shaw’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,000	Closed	-$873K	–	5303
2022 Q1	$873K	Hold	30,000	–	–	﹤0.01%	4022
2021 Q4	$986K	Buy	+30,000	New	+$1.21M	﹤0.01%	3936
2020 Q2	–	Sell	-105,800	Closed	-$3.75M	–	3960
2020 Q1	$3.75M	Buy	105,800 +25,800	+32%	+$1.19M	0.01%	1674
2019 Q4	$3.82M	Buy	80,000 +10,000	+14%	+$378K	﹤0.01%	1947
2019 Q3	$2.27M	Buy	+70,000	New	+$2.9M	﹤0.01%	2255
2019 Q2	–	Sell	-15,000	Closed	-$1.01M	–	3641
2019 Q1	$1.01M	Hold	15,000	–	–	﹤0.01%	2603
2018 Q4	$692K	Buy	+15,000	New	+$926K	﹤0.01%	2898
2015 Q2	–	Sell	-10,000	Closed	-$943K	–	3725
2015 Q1	$943K	Hold	10,000	–	–	﹤0.01%	2600
2014 Q4	$1.12M	Buy	+10,000	New	+$893K	﹤0.01%	2746

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's AGIO Position: Q2 2026 in Review

David Shaw increased its Agios Pharmaceuticals (AGIO) stake by 16% in Q2 2026, buying an estimated $12.9M and bringing the position to 3,107,005 shares worth $115M. The position accounts for 0.05% of the portfolio, ranked #395.

David Shaw first reported a position in AGIO in Q2 2014 and has held it in 41 quarters since. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

David Shaw held 3,107,005 shares of Agios Pharmaceuticals worth $115M as of Q2 2026.
David Shaw bought 425,836 Agios Pharmaceuticals shares in Q2 2026, an estimated $12.9M.
Agios Pharmaceuticals made up 0.05% of David Shaw's portfolio in Q2 2026, its #395 holding.
David Shaw first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 41 quarters since.
236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.